 Connection
Samer Al Hadidi to Female
This is a "connection" page, showing publications Samer Al Hadidi has written about Female.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.560 |
|
|
|
-
Kattamuri L, Mohan Lal B, Vojjala N, Jain M, Sharma K, Jain S, Al Hadidi S. Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review. Rheumatol Int. 2025 01 04; 45(1):18.
Score: 0.054
-
Al Hadidi S, Ababneh O, Schinke C, Thanendrarajan S, Bailey C, Tricot G, Shaughnessy J, Zhan F, Sawyer J, Siegel ER, Zangari M, Barlogie B, van Rhee F. Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma. Am J Hematol. 2024 Nov; 99(11):2222-2224.
Score: 0.053
-
Altarawneh H, Manasrah M, Al Shanableh Y, Saed Aldien A, Manasrah MA, Khan S, Altarawneh L, Al-Kraimeen LM, Al Kasaji F, Alareeki A, Al Hadidi S. Authorship characteristics of hematology and oncology education chapters: A comprehensive analysis. J Cancer Policy. 2024 Jun; 40:100484.
Score: 0.052
-
Syaj S, Al-Kraimeen L, Akhdar M, Abushukair H, Mohty R, Al Hadidi S. Gender and early-career faculty disparities in hematology and?oncology board review lecture series. Blood Adv. 2022 12 27; 6(24):6213-6218.
Score: 0.047
-
Al Hadidi S, Miller-Chism CN, Kamble R, Mims M. Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients With Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2020 09; 20(9):e579-e589.
Score: 0.039
-
Daher H, Towfiq B, Al Hadidi S. Gradually Worsening Pruritic Plaques. JAMA Oncol. 2018 Apr 01; 4(4):573-574.
Score: 0.034
-
Al Hadidi S, Aburahma A, Badami S, Upadhaya S. PARP (Poly(ADP-Ribose) Polymerase) Inhibitors in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis of Randomized Controlled Trials. Oncol Res Treat. 2018; 41(4):226-235.
Score: 0.034
-
Al Hadidi S. Timing of Pregnancy and Survival in Women With Breast Cancer. JAMA Oncol. 2018 01 01; 4(1):131.
Score: 0.033
-
Daher H, Al Hadidi S. Dysphagia lusoria presenting as epigastric pain. BMJ Case Rep. 2017 Dec 05; 2017.
Score: 0.033
-
Elounais F, Aburahma A, Alkotob ML, Al Hadidi S. Ventricular tachycardia after initiation of fingolimod. BMJ Case Rep. 2017 Sep 27; 2017.
Score: 0.033
-
Al Hadidi S, Wu K, Aburahma A, Alamarat Z. Family with clots: antithrombin deficiency. BMJ Case Rep. 2017 Aug 11; 2017.
Score: 0.032
-
Osman M, Al Salihi M, Abu Sitta E, Al Hadidi S. A rare case of Epstein-Barr virus mucocutaneous ulcer of the colon. BMJ Case Rep. 2017 Jul 06; 2017.
Score: 0.032
-
Al Hadidi S, Shaik Mohammed T, Bachuwa G. Unusual presentation of uterine leiomyoma. BMJ Case Rep. 2015 Apr 09; 2015.
Score: 0.028
-
Al Hadidi S, Towfiq B, Bachuwa G. Dystextia as a presentation of stroke. BMJ Case Rep. 2014 Nov 20; 2014.
Score: 0.027
-
Schinke C, Rasche L, Ashby C, van Hemert R, Thanendrarajan S, Al Hadidi S, Zangari M, Bailey C, Alapat DV, Shaughnessy JD, Zhan F, Barlogie B, van Rhee F, Weinhold N. Prognostic impact of focal lesion location and persistence in multiple myeloma: insights from serial PET/DWI imaging. Blood Adv. 2025 Sep 09; 9(17):4368-4377.
Score: 0.014
-
Sun F, Cheng Y, Ma C, Xu H, Bailey C, Mery D, Ashby TC, Alapat D, Li Y, Young KH, Al Hadidi S, Thanendrarajan S, Schinke C, Zangari M, van Rhee F, Tricot G, Shaughnessy JD, Zhan F. Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma. Cancer Biomark. 2025 Jun; 42(6):18758592251344936.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|